Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Frontiers in Oncology
|
September 24, 2013
Pre-clinical studies of epigenetic therapies targeting histone modifiers in lung cancer
Kenneth Huffman, Elisabeth D Martinez
The Journal of Biological Chemistry
|
June 11, 2002
Loss of androgen receptor transcriptional activity at the G(1)/S transition
Elisabeth D Martinez, Mark Danielsen
Methods in Enzymology
|
November 18, 2006
Development of assays for nuclear receptor modulators using fluorescently tagged proteins
Elisabeth D Martinez, Gordon L Hager
Epigenomics
|
February 27, 2016
Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms
Elisabeth D Martinez, Adi F Gazdar
Molecular & Cellular Oncology
|
October 24, 2017
JumonjiC demethylase inhibitors show potential for targeting chemotherapy-resistant lung cancers
Maithili P Dalvi, Elisabeth D Martinez
Experimental Cell Research
|
June 7, 2005
Analysis of the hormone-binding domain of steroid receptors using chimeras generated by homologous recombination
Elisabeth D Martinez, Nagarajan Pattabiraman, Mark Danielsen
Frontiers in Endocrinology
|
July 29, 2015
A Subset of Nuclear Receptors are Uniquely Expressed in Uveal Melanoma Cells
Kenneth Edward Huffman, Ryan Carstens, Elisabeth D Martinez
Future Medicinal Chemistry
|
October 30, 2015
Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential
Juan Bayo, Maithili P Dalvi, Elisabeth D Martinez
Oncotarget
|
November 19, 2016
Unique epigenetic gene profiles define human breast cancers with poor prognosis
Samuel Peña-Llopis, Yihong Wan, Elisabeth D Martinez
Journal of Natural Products
|
October 13, 2012
Anthraquinones from a marine-derived Streptomyces spinoverrucosus
Youcai Hu, Elisabeth D Martinez, John B MacMillan
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Frontiers in Oncology
|
September 24, 2013
Pre-clinical studies of epigenetic therapies targeting histone modifiers in lung cancer
Kenneth Huffman, Elisabeth D Martinez
The Journal of Biological Chemistry
|
June 11, 2002
Loss of androgen receptor transcriptional activity at the G(1)/S transition
Elisabeth D Martinez, Mark Danielsen
Methods in Enzymology
|
November 18, 2006
Development of assays for nuclear receptor modulators using fluorescently tagged proteins
Elisabeth D Martinez, Gordon L Hager
Epigenomics
|
February 27, 2016
Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms
Elisabeth D Martinez, Adi F Gazdar
Molecular & Cellular Oncology
|
October 24, 2017
JumonjiC demethylase inhibitors show potential for targeting chemotherapy-resistant lung cancers
Maithili P Dalvi, Elisabeth D Martinez
Experimental Cell Research
|
June 7, 2005
Analysis of the hormone-binding domain of steroid receptors using chimeras generated by homologous recombination
Elisabeth D Martinez, Nagarajan Pattabiraman, Mark Danielsen
Frontiers in Endocrinology
|
July 29, 2015
A Subset of Nuclear Receptors are Uniquely Expressed in Uveal Melanoma Cells
Kenneth Edward Huffman, Ryan Carstens, Elisabeth D Martinez
Future Medicinal Chemistry
|
October 30, 2015
Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential
Juan Bayo, Maithili P Dalvi, Elisabeth D Martinez
Oncotarget
|
November 19, 2016
Unique epigenetic gene profiles define human breast cancers with poor prognosis
Samuel Peña-Llopis, Yihong Wan, Elisabeth D Martinez
Journal of Natural Products
|
October 13, 2012
Anthraquinones from a marine-derived Streptomyces spinoverrucosus
Youcai Hu, Elisabeth D Martinez, John B MacMillan
Page
of 5